If this works out, then space-based chemical factories could produce superior drugs, such as insulin. This is because crystals grown in the microgravity environment of space often exhibit larger and more uniform structures compared to those produced on Earth.
“It has been suggested, for example, that insulin grown in space could be nine times more effective, allowing diabetic people to inject it once every three days instead of three times a day, as they often have to do today,” Bailet stated in the press release.
The developers are actively seeking funding to facilitate the first in-space demonstration of their technology.